Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 6:31 PM ET

Date/Time Source News Release
06/16/2025 08:00 AM EDT GlobeNewswire X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
06/10/2025 08:00 AM EDT GlobeNewswire X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
06/02/2025 04:05 PM EDT GlobeNewswire X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/14/2025 04:12 PM EDT GlobeNewswire X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
05/01/2025 06:01 AM EDT GlobeNewswire X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
04/24/2025 08:03 AM EDT GlobeNewswire X4 Pharmaceuticals to Report First-Quarter 2025 Financial Results and Host Conference Call and Webcast on May 1, 2025
04/24/2025 08:00 AM EDT GlobeNewswire X4 Pharmaceuticals Announces Reverse Stock Split
04/23/2025 04:05 PM EDT GlobeNewswire X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/25/2025 06:01 AM EDT GlobeNewswire X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
03/11/2025 08:00 AM EDT GlobeNewswire X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025
Page

Additional News

As of June 19, 2025 • 6:31 PM ET

Date/Time Source News Release
06/10/2025 08:12 AM EDT SeekingAlpha X4 Pharmaceuticals gains on fast-track designation for mavorixafor for treatment of chronic neutropenia
05/09/2025 12:31 PM EDT SeekingAlpha Healthcare stocks that could be poised for a rebound
05/01/2025 12:45 PM EDT SeekingAlpha X4 Pharmaceuticals targets $1-2B U.S. market for mavorixafor in chronic neutropenia
05/01/2025 12:44 PM EDT SeekingAlpha X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call Transcript
05/01/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 1st, 2025
05/01/2025 06:12 AM EDT SeekingAlpha X4 Pharmaceuticals beats Q1 estimates
05/01/2025 05:31 AM EDT US Earnings Reports Expected earnings - X4 Pharmaceuticals Inc.
04/30/2025 02:07 PM EDT SeekingAlpha X4 Pharmaceuticals Q1 2025 Earnings Preview
04/28/2025 09:00 AM EDT KlickAnalytics XFOR announced stock split 1-30
04/24/2025 08:17 AM EDT SeekingAlpha X4 Pharmaceuticals to conduct reverse stock split
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.